Large clinical trial seeks to prevent heart failure among childhood cancer survivors
- OPACC
- Jan 17, 2024
- 1 min read
Results suggest that more childhood cancer survivors may benefit from a heart-saving medication called carvedilol, even long after their cancer treatment is over.
Comments